Back to top
more

Amneal Pharmaceuticals (AMRX)

(Delayed Data from NSDQ)

$8.49 USD

8.49
922,984

+0.02 (0.24%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $8.48 -0.01 (-0.12%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 250)

Industry: Medical - Drugs

Better trading starts here.

Zacks News

Zogenix Gets FDA Nod for Dravet Syndrome Seizure Treatment

Zogenix (ZGNX) gets FDA nod for Fintepla oral solution, CIV for the treatment of seizures associated with Dravet Syndrome in patients 2 years of age or older.

Onconova Initiates Phase I/IIa Study on Lung Cancer Candidate

Onconova (ONTX) starts investigator-initiated phase I/IIa study of oral rigosertib plus Bristol-Myers Squibb's Opdivo in advanced metastatic KRAS-mutated lung adenocarcinoma.

AMRX vs. COLL: Which Stock Should Value Investors Buy Now?

AMRX vs. COLL: Which Stock Is the Better Value Option?

Jazz Pharmaceuticals (JAZZ) in Focus: Stock Moves 5.6% Higher

Jazz Pharmaceuticals (JAZZ) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

Moving Average Crossover Alert: Amneal Pharmaceuticals

Amneal Pharmaceuticals, Inc. (AMRX) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Actinium Pharmaceuticals (ATNM) Jumps: Stock Rises 6.7%

Actinium Pharmaceuticals (ATNM) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Amneal's Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Amneal Pharmaceuticals.

AMRX or COLL: Which Is the Better Value Stock Right Now?

AMRX vs. COLL: Which Stock Is the Better Value Option?

Tirthankar Chakraborty headshot

New Strong Buy Stocks For May 26th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

AMRX or COLL: Which Is the Better Value Stock Right Now?

AMRX vs. COLL: Which Stock Is the Better Value Option?

Amneal (AMRX) Moves to Buy: Rationale Behind the Upgrade

Amneal (AMRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Amneal's Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Amneal Pharmaceuticals.

Company News for May 12, 2020

Companies In The News Are:

Amneal Pharmaceuticals (AMRX) Surpasses Q1 Earnings and Revenue Estimates

Amneal (AMRX) delivered earnings and revenue surprises of 150.00% and 12.50%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Is a Surprise Coming for Amneal (AMRX) This Earnings Season?

Amneal (AMRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Are Options Traders Betting on a Big Move in Amneal Pharmaceuticals (AMRX) Stock?

Investors need to pay close attention to Amneal Pharmaceuticals (AMRX) stock based on the movements in the options market lately.

Amneal (AMRX) Catches Eye: Stock Jumps 6.7%

Amneal (AMRX) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Amneal Pharmaceuticals (AMRX) Beats Q4 Earnings and Revenue Estimates

Amneal (AMRX) delivered earnings and revenue surprises of 60.00% and 3.30%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

AMRX vs. ZTS: Which Stock Is the Better Value Option?

AMRX vs. ZTS: Which Stock Is the Better Value Option?

Amneal Pharmaceuticals Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor Amneal Pharmaceuticals

Kinjel Shah headshot

Prospects Appear Bright for Small Drug Industry in 2020

Successful innovation resulting in new drug approvals, important advances in clinical studies, frequent collaborations and M&A activity keep small drugmakers afloat in a competitive market.

Should Value Investors Pick Amneal Pharma (AMRX) Stock Now?

Let's see if Amneal Pharmaceuticals (AMRX) stock is a good choice for value-oriented investors right now from multiple angles.

AMRX vs. NBIX: Which Stock Is the Better Value Option?

AMRX vs. NBIX: Which Stock Is the Better Value Option?

Company News for Dec 13, 2019

Companies in the news are: FB, AMRX, LMPX, TNXP

Are Options Traders Betting on a Big Move in Amneal Pharmaceuticals (AMRX) Stock?

Investors need to pay close attention to Amneal Pharmaceuticals (AMRX) stock based on the movements in the options market lately.